< Back to Article

Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community

Fig 4

Strongyloides seroprevalence at baseline and month 12, by age group.

doi: https://doi.org/10.1371/journal.pntd.0005607.g004